Skip to main content
Article
Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis
Theranostics (2022)
  • Shawn Li
Disciplines
Publication Date
2022
Citation Information
Shawn Li. "Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis" Theranostics (2022)
Available at: http://works.bepress.com/shawn-li/3/